Forget me not: The effect of doxycycline on human declarative memory

• Published in: European neuropsychopharmacology Vol. 89; pp. 1 - 9
• Main Authors: Wehrli, Jelena M, Xia, Yanfang, Meister, Laura, Tursunova, Sarrina, Kleim, Birgit, Bach, Dominik R, Quednow, Boris B
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.12.2024
• Subjects: Adult; Attention - drug effects; Declarative memory; Double-Blind Method; Doxycycline; Doxycycline - pharmacology; Female; Humans; Male; Memory - drug effects; Memory modification; Neuroprotective; Neuropsychological Tests; Young Adult; Neuroprotective; Declarative memory; Doxycycline; Memory modification
• DOI: 10.1016/j.euroneuro.2024.08.006
• ISSN: 0924-977X; 1873-7862

Investigations into neuroprotective drugs are in high demand for the treatment of neurodegenerative diseases, such as multiple sclerosis or Alzheimer's disease, but also psychiatric disorders, such as depression, trauma, and substance use. One potential drug class being investigated are tetracyclines impacting on a variety of neuroprotective mechanisms. At the same time, tetracyclines like doxycycline have been suggested to affect human fear and spatial memory as well as reducing declarative memory retention. Based on the assumed necessity for synaptic consolidation in hippocampus-dependent learning, we hypothesised declarative memory may be similarly impaired by doxycycline as fear and spatial memory. Therefore, in this study we investigate the potential diminishing effects of doxycycline on consolidation of declarative memory in healthy humans. Additionally, to test for effect specificity we assessed motor memory, sustained attention, and processing speed. We administered a neuropsychological test battery in three independent randomized placebo-controlled double-blind trials (RCTs), in which healthy young volunteers (total N = 252) either received a single oral dose doxycycline (200 mg, n = 126) or placebo (n = 126) in a between-subject design. We found no evidence for a detrimental effect of doxycycline on declarative memory; instead, doxycycline improved declarative learning (p-value=0.022, Cohen's d=0.15) and memory consolidation (p=0.040, d=0.26). Contrarily, doxycycline slightly reduced motor learning (p=0.001, d=0.10) but subtly strengthened long-term motor memory (p=0.001, d=0.10). These results suggest that doxycycline can improve declarative learning and memory without having long term negative effects on other cognitive domains in healthy humans. Our results give hope to further investigate doxycycline in neuroprotective treatment applications.